Switch to:
GuruFocus has detected 1 Warning Sign with Cascadian Therapeutics Inc $CASC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Cascadian Therapeutics Inc (NAS:CASC)
Common Stock
$353.85 Mil (As of Mar. 2017)

Cascadian Therapeutics Inc's quarterly common stock declined from Sep. 2016 ($353.86 Mil) to Dec. 2016 ($353.85 Mil) but then increased from Dec. 2016 ($353.85 Mil) to Mar. 2017 ($353.85 Mil).

Cascadian Therapeutics Inc's annual common stock stayed the same from Dec. 2014 ($353.86 Mil) to Dec. 2015 ($353.86 Mil) but then declined from Dec. 2015 ($353.86 Mil) to Dec. 2016 ($353.85 Mil).


Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Cascadian Therapeutics Inc Annual Data

Common Stock 324.99325.04345.84353.85353.85353.85353.85353.86353.86353.85

Cascadian Therapeutics Inc Quarterly Data

Common Stock 353.86353.86353.86353.86353.86353.86353.86353.86353.85353.85
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)